The OTC Test market is projected to reach USD 22.2 billion by 2024 from USD 11.9 billion in 2018, at CAGR of 11.0%

Monday, April 15, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, April 15, 2019 /PRNewswire/ -- Increasing prevalence of infectious diseases is expected to drive the overall growth of the OTC Test market.

Read the full report: https://www.reportlinker.com/p05767330/?utm_source=PRN The OTC Test market is projected to reach USD 22.2 billion by 2024 from USD 11.9 billion
in 2018, at CAGR of 11.0% during forecast period. Diabetes is a prominent affliction across the globe and a key contributor to the demand for OTC tests. Infectious diseases also require rapid and effective testing. The need for tests for both applications has resulted in growing government support for the development and provision of OTC tests. However, the invasive nature of self-monitoring/traditional blood glucose systems and cholesterol monitoring is likely to affect market growth to a certain extent.The infectious disease tests segment is expected to grow at the highest CAGR during the forecast period.The OTC Test market, by product, has been categorized into eight major segments— glucose monitoring tests, cholesterol tests, pregnancy & fertility tests, drugs-of-abuse tests, coagulation monitoring tests, urinalysis tests, infectious disease tests, and other tests. The infectious disease tests segment is estimated to grow at the highest CAGR during the forecast period. This market is majorly driven by factors such as the increasing number of HIV-infected individuals across the globe, coupled with increasing availability and awareness about HIV OTC testing in emerging markets such as India, Brazil, and ChinaAsia Pacific projected to grow at the highest CAGR during the forecast period.In the OTC Test market, Asia Pacific is projected to record the highest growth during the forecast period.China, Japan, and India are the major markets for OTC Test in the Asia Pacific.Increasing prevalence of target conditions and infectious diseases and growing patient population base in emerging countries like India and China are expected to drive the growth of these markets during the forecast period.In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the OTC Test market.•?By Company Type: Tier 1–18%, Tier 2–39%, and Tier 3–43%•?By Designation: C-level Executives–25%, Directors–20%, and Others–55%•?By Region: North America–40%, Europe–27%, APAC–20%, and RoW–13%The OTC Test market comprises major providers such as OraSure Technologies (US), Roche Diagnostics (Switzerland), and i-Health Lab (US). The study includes an in-depth competitive analysis of these key players in the OTC Test market, along with their company profiles, recent developments, and key market strategies.Research Coverage:The market study covers the OTC Test market across various segments.It aims at estimating the market size and the growth potential of this market across different segments, on the basis of product, analyte type, product, end user, and region.The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.Key Benefits of Buying the Report:The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall OTC Test market and its subsegments.This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies.The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, and opportunities.Read the full report: https://www.reportlinker.com/p05767330/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/the-otc-test-market-is-projected-to-reach-usd-22-2-billion-by-2024-from-usd-11-9-billion-in-2018--at-cagr-of-11-0-300831972.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store